Tivicay PD Recall: Incorrect Expiration Date on Carton
GlaxoSmithKline recalls Tivicay PD 5mg tablets because the carton expiration date (May 2026) does not match the bottle label (April 2025).
Use caution until it’s fixed
Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.
Contact the company
What happened, in plain English
GlaxoSmithKline LLC is recalling specific cartons of Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension due to a labeling error. The outer carton displays an incorrect expiration date of May 2026, while the correct expiration date on the bottle label is April 2025. This discrepancy affects 463 cartons distributed nationwide within the United States. Read more at govinfonow.com/recall/32663-tivicay-pd-recall-incorrect-expiration-date-on-carton.
Source Summary by GovInfoNow · govinfonow.com/recall/32663-tivicay-pd-recall-incorrect-expiration-date-on-carton · Updated October 9, 2026 · FDA enforcement record: FDA #D-0544-2024
Cite this page
“Tivicay PD Recall: Incorrect Expiration Date on Carton.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/32663-tivicay-pd-recall-incorrect-expiration-date-on-carton. Based on FDA recall #D-0544-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0544-2024%22&limit=1).
Why it’s dangerous
The hazard is a labeling inconsistency where the carton's expiration date (May 2026) is later than the actual product expiration date found on the bottle label (April 2025). This could lead users to believe the medication is safe to use after its true expiration date has passed. The record does not state that the medication itself is unsafe or ineffective, only that the labeling is incorrect.
Who’s affected
Patients who have purchased or been prescribed Tivicay PD 5mg tablets in 60-count bottles from this specific recall lot. The risk is primarily for those relying on the carton date to determine if their medication is expired.
How to tell if you have this one
Check your Tivicay PD carton for an NDC of 49702-255-37 and Lot # AG4M. Look for a labeled expiry date on the carton of May 2026 (or 2026-MAY) while the bottle inside shows an expiration of April 2025 (or 04/2025). The product contains 60 tablets per bottle, along with a 30-mL dosing cup and a 10-mL oral dosing syringe.
- Brand
Tivicay- Category
Drug
What to do — step by step
Check Your Carton
Compare the expiration date on the outer carton against the date on the bottle label to identify if they differ as described in the recall.
Contact Healthcare Provider
Speak with your pharmacist or doctor to determine if you need a replacement for this specific lot, as no remedy is currently stated in the record.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0544-2024 (May 17, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0544-2024 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.